浙江医院位于杭州市灵隐路12号，毗邻西湖和杭州植物园，隶属于浙江省卫生厅，始建于1954年。建院初期以干部医疗保健和涉外医疗为主，1979年全面对外开放。目前是一所集医疗、教学、科研、预防和保健于一体的综合性三级甲等医院，也是杭州市西部急救中心。

During the past decade, Zhejiang Hospital conducted 30 clinical trials. In the 10-year time frame, 30 clinical trials started and 6 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 17 clinical trials started and 6 clinical trials were completed. i.e. 35.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Zhejiang Hospital" #1 sponsor was "First Affiliated Hospital of Zhejiang University" with 6 trials, followed by "Eli Lilly and Company" with 3 trials sponsored, "Boehringer Ingelheim" with 2 trials sponsored, "Chinese Academy of Medical Sciences, Fuwai Hospital" with 2 trials sponsored and "Pfizer" with 2 trials sponsored. Other sponsors include 14 different institutions and companies that sponsored additional 22 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Zhejiang Hospital" #1 collaborator was "Daiichi Sankyo (China) Holdings Co., Ltd." with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "Johnson & Johnson Medical (Shanghai) Ltd." with 1 trials as a collaborator, "LinkDoc Technology (Beijing) Co. Ltd." with 1 trials as a collaborator and "SciClone Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Zhejiang Hospital" are "Disorder of Consciousness" (5 trials), "Alzheimer Disease" (2 trials), "Intracranial Aneurysm" (2 trials), "Sepsis" (2 trials) and "Acute Pyelonephritis" (1 trials). Many other conditions were trialed in "Zhejiang Hospital" in a lesser frequency.

Most popular intervention types in "Zhejiang Hospital" are "Drug" (21 trials), "Device" (4 trials), "Other" (4 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Bismuth-Containing Quadruple Therapy" (2 trials), "Lansoprazole" (2 trials), "Lansoprazole Placebo" (2 trials) and "TAK-438" (2 trials). Other intervention names were less common.

The vast majority of trials in "Zhejiang Hospital" are 34 trials for "All" genders.

Currently, there are NaN active trials in "Zhejiang Hospital". 1 are not yet recruiting, 9 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Zhejiang Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Zhejiang Hospital, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 5 trials that are defined as “Not Applicable".